HD

TIER IV paves the way for highway trucking with innovative reference design

Retrieved on: 
Thursday, May 2, 2024
Brenner Pass, Perception, GNSS, Software, HD, POC, TIER, Satellite navigation

TOKYO, May 1, 2024 /PRNewswire/ -- TIER IV , a pioneer in open-source autonomous driving (AD) technology, today announced an exciting initiative aimed at shaping the future of highway trucking.

Key Points: 
  • TOKYO, May 1, 2024 /PRNewswire/ -- TIER IV , a pioneer in open-source autonomous driving (AD) technology, today announced an exciting initiative aimed at shaping the future of highway trucking.
  • By developing a reference design for commercial truck manufacturers, TIER IV is fully dedicated to facilitating the deployment of autonomous driving.
  • For the upcoming PoC tests, TIER IV is integrating the Mapless Autonomy Platform from a German start-up, driveblocks , into its AD software.
  • Through this new initiative, TIER IV is poised to steer the deployment of autonomous driving for highway trucking, making a significant leap forward in the industry.

Lagoon Furniture Returns to the HD Expo + Conference in Las Vegas

Retrieved on: 
Wednesday, May 1, 2024
Table, System, Climate, Ruta graveolens, Armchair, Conference, Environment, HD

LAS VEGAS, May 1, 2024 /PRNewswire/ -- Lagoon Furniture is keen to return to Las Vegas to attend The HD Expo + Conference, America's largest single destination event for in-person hospitality product discovery.

Key Points: 
  • LAS VEGAS, May 1, 2024 /PRNewswire/ -- Lagoon Furniture is keen to return to Las Vegas to attend The HD Expo + Conference, America's largest single destination event for in-person hospitality product discovery.
  • Lagoon Furniture is a highly respected indoor/outdoor designer, producer, and vendor committed to generating consistently industry-leading products for both commercial and domestic applications.
  • Lagoon Furniture will continue to leverage its strong Q1 2024 performance via participation in the furnishing industry's top tier trade shows throughout the remainder of 2024.
  • Meet Lagoon Furniture's team at its fabulous new booth at the Las Vegas HD Expo + Conference from April 30 to May 2, 2024 - your event experience wouldn't be complete without it!

Neurocrine Biosciences Announces U.S. FDA Approval of INGREZZA® SPRINKLE (valbenazine) Capsules

Retrieved on: 
Tuesday, April 30, 2024
FDA, Capsule, Dysphagia, Neurocrine Biosciences, Huntington's disease, Food, Tardive dyskinesia, HD, Patient, Chemistry, Caregiver, VMAT2, Chorea, SAN, Pharmaceutical industry

SAN DIEGO, April 30, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the U.S. Food and Drug Administration has approved INGREZZA® SPRINKLE (valbenazine) capsules, a new oral granules formulation of INGREZZA® (valbenazine) capsules prescribed for the treatment of adults with tardive dyskinesia and chorea associated with Huntington's disease.1 INGREZZA SPRINKLE provides an alternative administration option for those who experience dysphagia or have difficulty swallowing.

Key Points: 
  • SAN DIEGO, April 30, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the U.S. Food and Drug Administration has approved INGREZZA® SPRINKLE (valbenazine) capsules, a new oral granules formulation of INGREZZA® (valbenazine) capsules prescribed for the treatment of adults with tardive dyskinesia and chorea associated with Huntington's disease.1 INGREZZA SPRINKLE provides an alternative administration option for those who experience dysphagia or have difficulty swallowing.
  • "We developed INGREZZA SPRINKLE to make administration easier for patients who have difficulty swallowing or prefer not to take a capsule," said Eiry W. Roberts, M.D., Chief Medical Officer at Neurocrine Biosciences.
  • "We are pleased to offer the proven efficacy of INGREZZA in reducing uncontrollable movements in a new formulation."
  • ‡,†
    The U.S. Food and Drug Administration (FDA) approval was based on chemistry, manufacturing, and controls information and data demonstrating the bioequivalence and tolerability of INGREZZA SPRINKLE compared to INGREZZA capsules.

EQS-News: FORVIA HELLA starts fiscal year 2024 with slight sales growth

Retrieved on: 
Friday, May 3, 2024
HD, News, Series, Radar, Electronics, Lighting, Database, SSL, Growth

According to the data published today, Group sales in the first quarter 2024 (1 January to 31 March 2024) amounted to €2.0 billion (previous year: €2.0 billion).

Key Points: 
  • According to the data published today, Group sales in the first quarter 2024 (1 January to 31 March 2024) amounted to €2.0 billion (previous year: €2.0 billion).
  • This corresponds to currency-adjusted growth of 2.2 percent; reported sales increased by 0.6 percent.
  • Bernard Schäferbarthold, CEO of FORVIA HELLA: "We assume that the automotive market will only stagnate in 2024.
  • The full financial results for the first quarter of the fiscal year 2024 will be announced as planned on 25 April 2024.

Empowering Farmers: Drone Nerds Expands Agricultural Offerings with DJI Agras T50 and T25

Retrieved on: 
Thursday, April 25, 2024
Agras, Agriculture, Binocular vision, Map, 3D, T25, DJI, HD, T50, RF, Crop protection

Fort Lauderdale, FL, April 25, 2024 (GLOBE NEWSWIRE) -- Drone Nerds, a drone technology leader, has added DJI Agras T50 and T25 to its enterprise solutions.

Key Points: 
  • Fort Lauderdale, FL, April 25, 2024 (GLOBE NEWSWIRE) -- Drone Nerds, a drone technology leader, has added DJI Agras T50 and T25 to its enterprise solutions.
  • Whether it's navigating complex terrain or addressing specific crop care needs, the Agras T50 and T25 elevate drone agricultural operations to new heights.
  • "As the agricultural industry continues to evolve, the DJI Agras T50 and T25 stand out as game-changers.
  • At Drone Nerds, we're thrilled to provide our clients with such groundbreaking solutions from DJI, empowering them to achieve unprecedented levels of productivity and sustainability”,  states Jeremy Schneiderman, CEO of Drone Nerds.

CorMedix Inc. Announces CMS Grants TDAPA to DefenCath

Retrieved on: 
Friday, April 19, 2024
FDA, CMS, ESRD, Drug, Safety, CLS, Heparin, Food, Kidney failure, CVC, HD, Incidence, Patient, Medicare

Joseph Todisco, Chief Executive Officer of CorMedix commented, “CMS determination of TDAPA eligibility for DefenCath is a critical step toward ensuring this innovative preventative drug product is available for patients in the outpatient dialysis setting.

Key Points: 
  • Joseph Todisco, Chief Executive Officer of CorMedix commented, “CMS determination of TDAPA eligibility for DefenCath is a critical step toward ensuring this innovative preventative drug product is available for patients in the outpatient dialysis setting.
  • DefenCath is contraindicated and has warnings and precautions in patients with:
    Known hypersensitivity to any drug products in DefenCath, including taurolidine, heparin or the citrate excipient or pork products.
  • If exposure to either of the above occurs, discontinue use of DefenCath and institute appropriate supportive measures.
  • To report any safety concerns including suspected adverse reactions, contact CorMedix Inc. at 1-888-424-6345 or FDA at 1-800-FDA-1088 or visit www.fda.gov/medwatch .

Mobilicom and Airbus complete successful integration and flight proof-of-concept on Airbus Mid-Sized Jet-UAV for long-range operations

Retrieved on: 
Thursday, April 18, 2024
UAV, HD, MESH, Airbus, SWARM, Unmanned aerial vehicle, Robotics, Mobile phone

Mobilicom’s cybersecure long-range, high-speed communications systems were successfully integrated into Airbus’ Do-DT25 UAV, one of the top performing target drones in the world.

Key Points: 
  • Mobilicom’s cybersecure long-range, high-speed communications systems were successfully integrated into Airbus’ Do-DT25 UAV, one of the top performing target drones in the world.
  • The Mobilicom MCU-equipped Airbus Target Drones are designed to be used for military training purposes in battle scenarios that simulate various environments with different payloads.
  • Airbus’ Target Systems have been used to train armed forces worldwide in over 3,500 missions.
  • “The proof of concept marks a significant step forward in our end-to-end offering supporting our customers across mini, small and mid-sized platforms, including MESH networking solution for fleet and SWARM operations.”

CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath® (Taurolidine and Heparin)

Retrieved on: 
Monday, April 15, 2024
FDA, CMS, Risk, Safety, CLS, Heparin, Food, Kidney failure, HD, Incidence, Patient, Medicare, Taurolidine, CVC, HCPCS, Medical device

We are proud to provide an option for adult patients who face the risk of CRBSIs.

Key Points: 
  • We are proud to provide an option for adult patients who face the risk of CRBSIs.
  • We look forward to expanding the availability of DefenCath to the outpatient setting later this year.”
    The commencement of U.S. outpatient commercialization of DefenCath is planned for July 1, 2024.
  • If exposure to either of the above occurs, discontinue use of DefenCath and institute appropriate supportive measures.
  • To report any safety concerns including suspected adverse reactions, contact CorMedix Inc. at 1-888-424-6345 or FDA at 1-800-FDA-1088 or visit www.fda.gov/medwatch .

Best Nomos, A TeamBest Global Company, Launches Its Most Modern, Highly Innovative Compact SONALIS Ultrasound System

Retrieved on: 
Monday, April 29, 2024
Medical Devices, Surgery, Neurology, Health Technology, Cardiology, Biotechnology, Radiology, General Health, Health, Oncology, Brachytherapy, System, Prostate, Mammography, LDR, Compact, Human musculoskeletal system, BCF, HD, Cyclotron, HDR, Health physics, TBG, Diagnosis, Perineum, Breast cancer, Medical imaging

Best Nomos, a TeamBest Global Company, is launching its most modern, highly innovative Compact SONALIS Ultrasound System .

Key Points: 
  • Best Nomos, a TeamBest Global Company, is launching its most modern, highly innovative Compact SONALIS Ultrasound System .
  • With its previous hallmark, patented SimulView™ Technology, the system provides superior visualization of HDR, LDR, Tranperineal Biopsies, fiducial marker placements, or any other procedure that can be performed with a transrectal ultrasound system.
  • SimulView™ Technology provides simultaneous “live” views of the prostate in both planes, thereby increasing treatment accuracy and precision.
  • To see a video about Best Nomos's Compact Sonalis Ultrasound System, please go to http://www.teambest.com/videos/Best-nomos-Compact-Sonalis-1080p.mp4 .

Invitation to press - and audio conference regarding Skanska's Interim report first quarter 2024 on May 8

Retrieved on: 
Tuesday, April 30, 2024
High definition, Skanska, CFO, Senior, Public affairs, HD, Q&A, Management

STOCKHOLM, April 30, 2024 /PRNewswire/ -- Skanska's Interim report first quarter 2024 will be released on Wednesday, May 8 at 07:30 am CEST.

Key Points: 
  • STOCKHOLM, April 30, 2024 /PRNewswire/ -- Skanska's Interim report first quarter 2024 will be released on Wednesday, May 8 at 07:30 am CEST.
  • The report will be presented by Anders Danielsson, Skanska's President and CEO, and Magnus Persson, CFO, at a press- and audio conference at 10:00 am CET at Skanska's head office at Warfvinges väg 25 in Stockholm.
  • The press conference will be webcasted live at www.skanska.com/investors , where it also will be posted shortly afterwards.
  • Participate in the audio conference, with the possibility to ask questions:
    To improve the quality of sound during the Q&A for participants and presenters we are now providing an additional high quality audio link.